HealthStream Inc has a consensus price target of $32 based on the ratings of 3 analysts. The high is $34 issued by Barclays on October 23, 2024. The low is $30 issued by Canaccord Genuity on February 26, 2025. The 3 most-recent analyst ratings were released by Canaccord Genuity, Barclays, and Canaccord Genuity on February 26, 2025, October 23, 2024, and October 23, 2024, respectively. With an average price target of $31 between Canaccord Genuity, Barclays, and Canaccord Genuity, there's an implied -7.30% downside for HealthStream Inc from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for HealthStream (NASDAQ:HSTM) was reported by Canaccord Genuity on February 26, 2025. The analyst firm set a price target for $30.00 expecting HSTM to fall to within 12 months (a possible -10.29% downside). 5 analyst firms have reported ratings in the last year.
The latest analyst rating for HealthStream (NASDAQ:HSTM) was provided by Canaccord Genuity, and HealthStream maintained their hold rating.
There is no last upgrade for HealthStream
There is no last downgrade for HealthStream.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of HealthStream, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for HealthStream was filed on February 26, 2025 so you should expect the next rating to be made available sometime around February 26, 2026.
While ratings are subjective and will change, the latest HealthStream (HSTM) rating was a maintained with a price target of $29.00 to $30.00. The current price HealthStream (HSTM) is trading at is $33.44, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.